Lifang Wang
- Topics
- Cardiovascular Health and Disease Prevention (4 papers)Parathyroid Disorders and Treatments (3 papers)Cholesterol and Lipid Metabolism (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaEnvironmental PollutionClinical Orthopaedics and Related Research
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lifang Wang
38 papers receiving 466 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 132
- Epidemiology 121
- Nephrology 75
- Genetics 53
- Surgery 48
Countries citing papers authored by Lifang Wang
This map shows the geographic impact of Lifang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Wang more than expected).
Fields of papers citing papers by Lifang Wang
This network shows the impact of papers produced by Lifang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Wang. The network helps show where Lifang Wang may publish in the future.
Co-authorship network of co-authors of Lifang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Lifang Wang. A scholar is included among the top collaborators of Lifang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifang Wang. Lifang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 14 | |
| 10 | 3 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | 10 | |
| 15 | 0 | |
| 16 | 28 | |
| 17 | α-Adducin gene G614T polymorphisms in essential hypertension patients with high low density lipoprotein (LDL) levels. | 7 |
| 18 | 128 | |
| 19 | 2 | |
| 20 | 19 |
About Lifang Wang
Lifang Wang is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Anesthesiology and Pain Medicine, having authored 42 papers that have together received 473 indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (4 papers), Parathyroid Disorders and Treatments (3 papers) and Cholesterol and Lipid Metabolism (3 papers). The work is most often cited by research in Nephrology (75 citations), Epidemiology (121 citations) and Critical Care and Intensive Care Medicine (16 citations). Lifang Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Pei-Chi Chiang, Yen‐Hsu Chen, Shu‐Mien Chuang, Chin Hsu, Qianqian Ma, Jianke Li, Wei Zhao, Weihua Yue, Tianlan Lu and Hao Yan. Their work appears in journals such as SHILAP Revista de lepidopterología, Environmental Pollution and Clinical Orthopaedics and Related Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.